Nuedexta in Treatment-Resistant Major Depression
NCT01882829
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Major Depressive Disorder
Treatment Resistant
Interventions
DRUG:
dextromethorphan/quinidine
Sponsor
James Murrough